Propofol infusion syndrome: Presentation, pathophysiology and therapy of a rare complication;Das Propofol-Infusionssyndrom. Klinik, Pathophysiologie und Therapie einer seltenen Komplikation

Deutsches Arzteblatt

Volumn 103, Issue 11, 2006, Pages

  Wappler, Frank ^a  

^a KRANKENHAUS MERHEIM   (Germany)

Author keywords

Acidosis; Anaesthesia; Analgesia; Infusion therapy; Propofol

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CATECHOLAMINE; CREATINE KINASE MB; FATTY ACID; GLUCOCORTICOID; HYPNOTIC AGENT; LACTIC ACID; MIDAZOLAM; PHOSPHODIESTERASE INHIBITOR; PROPOFOL;

ANESTHESIA INDUCTION; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CREATINE KINASE BLOOD LEVEL; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG ELIMINATION; DRUG FATALITY; DRUG MECHANISM; DRUG MEGADOSE; DRUG METABOLISM; DRUG WITHDRAWAL; ENERGY BALANCE; FATTY ACID METABOLISM; HEMODIALYSIS; HEMODYNAMICS; HEMOFILTRATION; HEPATOMEGALY; HUMAN; HYPERKALEMIA; HYPERTHERMIA; INTENSIVE CARE; KIDNEY FAILURE; LABORATORY TEST; LACTIC ACIDOSIS; METABOLIC DISORDER; METABOLIC PARAMETERS; MITOCHONDRIAL ENERGY TRANSFER; MITOCHONDRION; MYOGLOBINURIA; PATHOPHYSIOLOGY; PATIENT MONITORING; PROPOFOL INFUSION SYNDROME; RHABDOMYOLYSIS; RISK FACTOR; SEDATION; SHORT COURSE THERAPY;

EID: 34247551079     PISSN: 00121207     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Martin J, Bäsell K, Bürkle H et al.: Leitlinien zur "Analgesie und Sedierung in der Intensivmedizin". Anästh Intensivmed 2005; 46: S1-20.
2. Soliman HM, Mélot C, Vincent JL: Sedative and analgesic practice in the intensive care unit: the results of an European survey. Br J Anaesth 2001; 87:186-92.
3. Hall RI, Sandham D, Cardinal P et al.: Propofol vs midazolam for ICU sedation: a Canadian multicenter randomized trial. Chest 2001; 119: 1151-9.
4. Playfor SD, Venkatesh K: Current patterns of propofol use in PICU in the United Kingdom and North America. Paediatr Anaesth 2004; 14: 501-4.
5. Parke TJ, Stevens JE, Rice ASC et al.: Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports. BMJ 1992; 305: 613-6
6. Barclay K, Williams AJ, Major E: Propofol infusion in children. BMJ 1992; 305: 953.
7. Bray RJ: Propofol infusion syndrome in children. Paed Anaesth 1998; 8: 491-9.
8. Cannon ML, Glazier SS, Bauman LA: Metabolic acidosis, rhabdomyolysis, and cardiovascular collapse after prolonged propofol infusion. J Neurosurg 2001;95:1053-6.
9. Hein S, Benken I, Quintel M, Kettler D: Das Propofol-Infusions-Syndrom. Anästh Intensivmed 2004; 45. 580-4.
10. Holzki J, Aring C, Gillor A: Death after re-exposure to propofol in a 3-year-old child: a case report. Paediatr Anaesth 2004; 14: 265-70,
11. Strickland RA, Murray MJ: Fatal metabolic acidosis in a pediatric patient receiving an infusion of propofol in the intensive care unit: is there a relationship? Crit Care Med 1995; 23: 405-9.
12. Stelow EB, Johari VP, Smith SA, Crosson JT, Apple FS: Propofol-associated rhabdomyolysis with cardiac involvement in adults: chemical and anatomic findings. Clin Chem 2000; 46: 577-81.
13. Hanna JP, Ramundo ML: Rhabdomyolysis and hypoxia associated with prolonged propofol infusion in children. Neurology 1998; 50: 301-3.
14. Burow BK, Johnson ME, Packer DL: Metabolic acidosis with propofol in the absence of other causative factors. Anesthesiology 2004; 101: 239-41.
15. Vasile B, Rasulo F, Candiani A, Latronico N: The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med 2003; 29:1417-25.
16. Liolos A, Guérit JM, Scholtes JL, Raftopoulos C, Hantson P: Propofol infusion syndrome associated with short-term large-dose infusion during surgical anesthesia in an adult. Anesth Analg 2005; 100: 1804-6.
17. Mehta N, DeMunter C, Habibi R Nadel S, Britto J: Short-term propofol infusions in children. Lancet 1999;354:866-7.
18. Salengros J-C, Velghe-Lenelle C-E, Bollens R, Engelman E, Barvais L: Lactic acidosis during propofol-remifentanil anesthesia in an adult. Anesthesiology 2004; 101: 241-3.
19. Motsch J, Roggenbach J: Propofol-Infusionssyndrom. Anaesthesist 2004; 53: 1009-24.
20. Wolf A, Weir P, Segar R Stone J, Shield J: Impaired fatty acid oxidation in propofol infusion syndrome. Lancet 2001;-357: 606-7.
21. Cray SH, Robinson BH, Cox PN: Lactic academia and bradyarrhythmia in a child sedated with propofol. Crit Care Med 1998; 26: 2087-92.
22. Spiekerkötter U, Bennett MJ, Ben-Zeev B, Strauss AW, Tein I: Peripheral neuropathy, episodic myoglobinuria, and respiratory failure in deficiency of the mitochondrial trifunctional protein. Muscle Nerve 2004; 29: 66-72.
23. Cremer OL, Moons KGM, Bouman EAC, Kruijswijk JE, de Smet AMGA, Kalkman CJ: Long-term propofol infusion and cardiac failure in adult head-injured patients. Lancet 2001; 357: 117-8.
24. Mitteilungen der Bundesärztekammer. Schwere unerwünschte Arzneimittelwirkunge nach Propofol-Infusionen zur Sedierung. Dtsch Arztebl 2004; 101: A 3447 [Heft 50].
25. Goodale D: Letter from Astra Zeneca to US physicians. Wilmington DE, USA, 26th March 2001.